Erweiterte Suche

Yvonne L. Greenstreet gründete Highgate LLC. Derzeit ist Dr. Greenstreet President & Chief Operating Officer von Alnylam Pharmaceuticals, Inc. Dr. Greenstreet ist auch im Vorstand von Pacira Biosciences, Inc. und Mitglied der Association of the British Pharmaceutical Industry. Dr. Greenstreet war zuvor Geschäftsführerin bei Highgate LLC, Senior Vice President & Head-Medicines Development bei Pfizer Inc. und Chief Strategy-R&D, Senior Vice President bei GlaxoSmithKline Plc. Yvonne L. Greenstreet erhielt einen MBA von INSEAD und einen Bachelor-Abschluss von der University of Leeds.

Michelle M.
Greenstreet formerly worked at Citibank NA (New York), as Senior Vice President & Director-Human Resource, United Parcel Service, Inc., as Principal, Texas Workforce Commission, as Principal, Caliber Home Loans, Inc., as Chief Human Resources Officer & Executive VP from 2012 to 2014, Vericrest Financial, Inc., as Chief Human Resources Officer, and Spirit Realty Capital, Inc., as Chief Administrative Officer & Executive VP.
Ms. Greenstreet received her undergraduate degree from Texas A&M University.

Stephen Greenstreet has worked as a Managing Director at XPS Pensions Ltd.
since 2012.

Gary Greenstreet is currently a Member-Managers Board member at UMC Health System.
Previously, he worked as an Office Manager at Stark Street Lawn & Garden, Inc.

Ian O.
Greenstreet is the founder of Infinity Capital Partners Ltd.
He currently holds positions as an Independent Non-Executive Director at The Principality Building Society and at Simmons & Simmons LLP.
Previously, he held positions as an Independent Non-Executive Director at Lesaka Technologies, Inc., an Independent Director at Diamond Bank Plc, and as a Director & Head at Henderson Fund Management (Luxembourg) SA, among others.
He received his undergraduate degree from The University of Manchester.